Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • LLY vs GSK✓SelectedUSD · GSKLLY vs GSK performance historyLatest closeAs of-0.82%11/16
Stock and ETF performance explorer

LLY vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+480.1%
GSK return
+46.9%
Excess return
+433.2%
Maximum drawdown
-34.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.8%-0.1%-0.7%-0.8%
7D+1.5%-1.3%+2.8%+2.1%
30D+14.0%+2.7%+11.3%+12.6%
3M+21.5%+2.7%+18.7%+20.1%
6M+42.8%+3.3%+39.5%+40.8%
YTD+34.0%+6.5%+27.6%+30.6%
1Y+40.5%+10.7%+29.8%+34.9%
3Y+148.1%+64.4%+83.7%+100.6%
5Y+480.1%+46.7%+433.4%+357.6%
All+480.1%+46.9%+433.2%+357.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling